STAT+: FTC will investigate pharmacy benefit managers and their role in prescription drug costs
After months of deliberation, the U.S. Federal Trade Commission has voted unanimously to investigate several…
Category: Pharmalot
STAT+: Pharmalittle: FDA panel will scrutinize Novavax shot for Covid-19; J&J and Emergent accuse each other of breach
Top of the morning to you, and a fine one it is. Blue skies and…
STAT+: Former Lilly manager files whistleblower lawsuit over manufacturing failures at production plant
A former Eli Lilly human resources officer sued the drug company after claiming she lost…
STAT+: ‘All about strengthening health systems’: New coalition pushes to license cancer drugs to low-income countries
Over the past two decades, public health officials and patient advocacy groups have pushed the…
STAT+: Pharmalittle: Cancer drug trial yields remission in every patient; Novartis data hacked by extortionists
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: Bristol Myers will pay $4.1 billion for Turning Point; Europe looks to approve a smallpox vaccine for monkeypox
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Pharmalittle: ‘Gloomy’ report issued on WTO Covid-vaccine proposal; biotech ‘swoon’ hits enterprise value at many companies
Rise and shine, everyone, another busy day is on the way. This morning is getting…
STAT+: Italian authorities fine drugmaker for ‘excessive’ pricing of a rare disease drug
Antitrust regulators in Italy have fined a drugmaker nearly $3.8 million for years of “excessive”…
.jpg)
STAT+: Pharmalittle: Pfizer to exit consumer-health joint venture with GSK; access to obesity drugs in U.S. remains ‘dismal’
Top of the morning to you, and a fine one it is, despite the cloudy…
STAT+: Former AstraZeneca executive charged with insider trading over Daiichi cancer drug deal
A former AstraZeneca communications executive was accused of insider trading in connection with a partnership…
STAT+: Documents show problems at Novartis facility where cancer drug production was halted
Earlier this month, Novartis took the surprising step of voluntarily suspending production of two therapies…
STAT+: Pharmalittle: GSK to pay up to $3.3 billion for Affinivax; Senate bill tries to avoid another Aduhelm controversy
Good morning, everyone, and welcome to another working week. We hope the weekend respite, which…
STAT+: While a law designed to thwart counterfeit medicines lurches into full force, fake pills keep circulating
As far as Shane Jerominski was concerned, the many bottles of a widely used HIV…
STAT+: The World Health Assembly moves to bolster clinical trials, but some say it falls short
In response to the Covid-19 pandemic, the World Health Assembly adopted a resolution designed to…
STAT+: ViiV will make it easier for generic companies to copy its HIV prevention shot, but it’s not clear when
In response to criticism, ViiV Healthcare has agreed to license its long-acting injectable HIV prevention…
STAT+: Pharmalittle: Will widening access to a Covid pill cause resistance? Monkeypox vaccine maker doesn’t see ‘panic’
And so, another working week will soon draw to a close. This is, as you…
STAT+: As monkeypox spreads, Bavarian Nordic’s CEO is fielding calls for his vaccine, but doesn’t see panic
As monkeypox threatens to become the latest global health concern, Bavarian Nordic has suddenly become…
STAT+: Pharmalittle: Teva and Allergan reach $161 million opioid settlement with West Virginia; FDA lifts hold on Bharat Covid shot
Hello, everyone, and how are you today? A steely gray sky is hovering this morning…
STAT+: Pharmalittle: Pfizer to sell medicines and vaccines to poor countries at low prices; Germany orders vaccine to combat monkeypox
Hello, everyone, and how are you this fine, sunny morning? Birds are chirping and cool…
STAT+: Pfizer will sell its patent-protected medicines and vaccines to poor countries at low prices
In an ambitious move to widen access to its medical products, Pfizer said Wednesday that…
STAT+: Pharmalittle: Is the Covid-19 gold rush over for drugmakers? Monkeypox attracts interest from vaccine makers
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: Pharmalittle: Pfizer and BioNTech seek Covid-vaccine use in kids under 5; Pfizer refunds $290,000 over misleading coupons
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pfizer to refund $290,000 to consumers in four states over misleading copay couponds
Amid controversy over the use of patient coupons, Pfizer has agreed to refund $290,000 to…
STAT+: European regulator suspends generic drugs after finding flawed studies
In the latest dust-up over the safety of medicines, the European Medicines Agency recommended suspending…
STAT+: Pharmalittle: Cancer coalition aims to boost access to meds in poor countries; Moderna’s vaccine patent defense poses shield for others
And so, another working week will soon draw to a close. This is, as you…
STAT+: Pharmalittle: Pfizer resists requests for study supplies of its Covid pill; WTO talks on Covid vaccine patent waivers are bogged down
Good morning, everyone, and how are you today? The skies over the Pharmalot campus are…
STAT+: Pharma wins a court battle over an HHS rule that would have penalized them for offering copay coupons
In a notable win for the pharmaceutical industry, a federal court judge tossed a rule…
STAT+: ‘Pharma bro’ Martin Shkreli released from prison
Martin Shkreli, the infamous ‘pharma bro’ who was sentenced to prison for securities fraud, was…
STAT+: Pharmalittle: Moderna chair defends executive hiring process; analysis finds monopoly tactics preserve inhaler revenues
Good morning, everyone, and how are you today? We are doing just fine, thank you….
STAT+: Drugmakers use monopoly tactics to thwart lower-cost generic competition for inhalers, analysis finds
For more than three decades, drugmakers have used various tactics to win and extend monopolies…
STAT+: High blood pressure pills are costly — but also hard to find — in some lower-income countries
A clutch of serious challenges — high prices, a lack of effective combination pills, and…
STAT+: Pharmalittle: FDA declines to approve old antidepressant for Covid; U.S.-China trade fight may derail WTO Covid patent waiver
Rise and shine, another busy day is on the way. However, this is also shaping…
STAT+: Two dozen states side with HHS in its raucous dispute with pharma over a drug discount program
Two dozen states have waded into the heated dispute between the U.S. government and a…
STAT+: Greece plans to go to court to seek compensation from Novartis over a bribery scandal
The Greek health ministry plans to seek compensation from Novartis over a long-running bribery scandal…
STAT+: Pharmalittle: FDA OKs new type of diabetes drug from Lilly; Early-stage biotechs are juicy targets for M&A surge
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: Aspen may close South Africa Covid vaccine plant due to lack of orders; Roche insists it can overcome latest setback
And so, another working week will soon draw to a close. Not a moment too…
STAT+: National Institutes of Health licenses nearly a dozen Covid-19 technologies to a WHO program
In a notable bid to widen global access to Covid-19 medical products, the National Institutes…
STAT+: Arkansas becomes the latest state to sue drugmakers and PBMs over insulin pricing
The Arkansas attorney general has filed a lawsuit accusing several drugmakers and pharmacy benefit managers…
STAT+: Pharmalittle: Seagen chief executive is arrested for domestic assault; abortion pill producer has ample supplies
Top of the morning to you. Gray skies are hovering over the Pharmalot campus right…
STAT+: Lawmakers wade into a contentious and long-running battle over orphan drug monopolies
Sparked by an unusual, decade-long fight over a rare disease drug, two U.S. lawmakers have…
STAT+: Pharmalittle: Moderna’s new CFO leaves due to probe by former employer; Roche suffers another setback with a cancer drug
Top of the morning to you. The middle of the week is upon us and,…
STAT+: Why a controversial patent rights waiver could be a ‘missed opportunity’ to tackle the next pandemic
After 18 months, the fate of a contentious proposal before the World Trade Organization to…
STAT+: Pharmalittle: Pfizer to pay $11.6 billion for Biohaven; pharmacy chains face a novel trial to determine opioid liability
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: Pharmalittle: Seagen CEO under investigation after alleged domestic violence; Bausch & Lomb settles for a lesser IPO
Good morning, one and all. Damian Garde here, filling in for Ed Silverman on another…
STAT+: Pharmalittle: FDA restricts access to J&J Covid-19 vaccine; Novartis halts production of two cancer drugs over quality issues
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Novartis suspends production of two cancer therapies over potential quality issues
Due to manufacturing issues, Novartis has voluntarily suspended production of two therapies that use nuclear…
STAT+: Pharmalittle: Abortion pill demand may rise if Roe v Wade is overturned; U.S. lawmakers move toward revamping accelerated approval
Top of the morning to you. Another deliciously shiny day is unfolding over the Pharmalot…
STAT+: J&J sues a behind-the-scenes company for exploiting its patient assistance program
In the latest dust-up over prescription drug pricing, Johnson & Johnson filed a lawsuit accusing…
STAT+: Race is often overlooked in key clinical trial data used to win new drug approvals in Europe
Just two-thirds of the pivotal clinical trials that were used to win prescription drug approvals…
STAT+: FDA warns Miami University contract testing lab over falsified data, poor quality control
A contract testing laboratory run by Miami University was scolded by the U.S. Food and…